Center Overview

The TWS -Clinical Research Center is a dedicated research department of a four physician, two nurse practitioner OB-GYN medical practice. The medical director has been involved in clinical trials for over twenty years, and the clinical research coordinators are experienced and certified. We have on-site advanced ultrasound, Urodynamics and are close to facilities for dexa scanning and mammograms. We pride ourselves in accomplishing leading edge studies safely and successfully.

Clinical Research Experience

Our site specializes in women's health care issues including hormone therapy, contraception, incontinence, osteoporosis, PMS, breast pain, endometriosis, fibroids, and sexual dysfunction. Over the last twenty years, we have worked with over twenty different sponsors and CRO's including most recently:Americas Doctor/ Essential

Facility Description

Our center is located in Tacoma Washington, across the street from a level III hospital with complete lab and surgical facilities. We are able to offer ultrasounds in the office as well as collect most lab specimens (biopsies, Pap smears and blood draws). There is readily available covered parking and public transportation adjacent to our site.

Investigator Experience

Dr. Lenihan, the medical director, is a board certified Obstetrician-Gynecologist who has over 22 years experience in clinical trials. He is on faculty at the Univ. of Washington School of Medicine, has published over 16 scientific articles, speaks frequently at medical education conferences, and is a member of many professional societies and organizations.

Dr. Clare Cammarano is also a board certified OB-GYN physician with over eight years experience in clinical trials. She serves as a principal investigator and sub investigator on many studies.

Terry Silvestrin ARNP is an experienced clinician who functions as a sub-investigator with over eight years experience in clinical trails. She is a certified menopausal clinician by NAMS (the North American Menopause Society)

Staff Expertise

CRC's:
Judith Hall, CCRC: Over nineteen years in clinical trial experience.

Paula Brandon, CCRC: Over ten years experience in women's health studies.

Patient Demographics

Our population is primarily middle and upper middle classes, drawn from Pierce County (Tacoma Washington), South King County (Federal Way, WA), and North Thurston County (Olympia WA). Many of our study subjects are patients in our practice, and others are referred from referring primary care offices. We have patients ranging from teenagers to senior citizens.

Other Information

We always utilize a central IRB. We have a separate storage facility for study documents older than two years. And we have space provided for monitors and study representatives who visit. Our center is located an easy thirty minute drive south of SeaTac airport. We are forty five minutes south of Seattle.

Contact Information

Michelle King
Administrator
Tacoma Women's Specialists Clinical Research Center
314 M. L. King Jr Way, Suite #104
Tacoma, WA 98405
USA
Phone: 253-272-5572
Fax: 253-272-5699
EMail: jplenihan@tacomaobgyn.com
Web Site: http://www.tacomaobgyn.com

Currently Enrolling Trials

• A Phase III, multicenter, randomized, double-blind, parallel group study to evaluate the efficacy and safety of two doses of Dr-3001 versus placebo in Women with overactive bladder.
• A Phase III, multicenter, randomized, double-blind, parallel group study to evaluate the efficacy and safety of two doses of Dr-3001 versus placebo in Women with overactive bladder.
• A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive bladder including urge urinary incontinence. Phase II study
• A Placebo controlled randomized, 12 week, dose-range, double blindstudy versus placebo using tolterodine as a study calibrator, to evaluate efficacy and safety of SSR240600C in Women with overactive bladder including urge urinary incontinence. Phase II study
• This is a Phase IIIb, multi-center, open label, randomized, study that compares the safety and tolerabilty of Intravenous Ferric Carboxymaltose(FCM) vs. standard medical care in postpartum and heavy uterine bleeding subjects with iron deficiency
• This is a Phase IIIb, multi-center, open label, randomized, study that compares the safety and tolerabilty of Intravenous Ferric Carboxymaltose(FCM) vs. standard medical care in postpartum and heavy uterine bleeding subjects with iron deficiency

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.